|Country||Thailand - SIR Ranking of Thailand||
|Subject Area and Category||Medicine|
Pharmacology, Toxicology and Pharmaceutics
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
|Publisher||Mahidol University - Faculty of Pharmacy|
|Scope||The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: -Clinical Pharmacy- Drug Synthesis and Discovery- Targeted-Drug Delivery- Pharmaceutics- Biopharmaceutical Sciences- Phytopharmaceutical Sciences- Pharmacology and Toxicology- Pharmaceutical Chemistry- Nutraceuticals and Functional Foods- Natural Products- Social, Economic, and Administrative Pharmacy- Clinical Drug Evaluation and Drug Policy Making- Antimicrobials, Resistance and Infection Control- Pharmacokinetics and Pharmacodynamics.|
|Join the conversation about this journal|
The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
|Pharmacology, Toxicology and Pharmaceutics (miscellaneous)||2018||Q4|
|Pharmacology, Toxicology and Pharmaceutics (miscellaneous)||2019||Q4|
The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
|Cites per document||Year||Value|
|Cites / Doc. (4 years)||2017||0.000|
|Cites / Doc. (4 years)||2018||0.190|
|Cites / Doc. (4 years)||2019||0.167|
|Cites / Doc. (3 years)||2017||0.000|
|Cites / Doc. (3 years)||2018||0.190|
|Cites / Doc. (3 years)||2019||0.167|
|Cites / Doc. (2 years)||2017||0.000|
|Cites / Doc. (2 years)||2018||0.190|
|Cites / Doc. (2 years)||2019||0.167|
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.
|External Cites per document||2017||0|
|External Cites per document||2018||0.190|
|External Cites per document||2019||0.167|
|Cites per document||2017||0.000|
|Cites per document||2018||0.190|
|Cites per document||2019||0.167|
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.